122
Participants
Start Date
December 31, 2011
Primary Completion Date
September 30, 2012
Study Completion Date
February 28, 2013
IV morphine sulfate or Sponsor-approved equivalent
Patients in this group will receive IV morphine sulfate or Sponsor-approved equivalent via a patient-controlled analgesia (PCA) pump, as needed. The PCA pump will be set up postsurgically as soon as possible and prior to the patient leaving the post-anesthesia care unit (PACU) or immediately upon transfer to a floor if the stay in the PACU is less than one hour.
EXPAREL
"Patients will receive 266 mg EXPAREL diluted with preservative-free 0.9% normal saline to a total volume of 40 cc administered via wound infiltration prior to wound closure. When not contraindicated, 30 mg IV ketorolac will be given at the end of surgery. If not indicated, an IV non-steroidal anti-inflammatory drug (NSAID) may be substituted per the site's standard of care.~All patients will be offered rescue analgesia, as needed."
Albany Medical College, Albany
Washington Hospital Center, Washington D.C.
University of Miami, Dept. Anesthesiology, Miami
Tampa General Hospital, Tampa
The Ohio State University Medical Center, Columbus
Methodist Hospital, Houston
Lead Sponsor
Registrat-Mapi
OTHER
Pacira Pharmaceuticals, Inc
INDUSTRY